美康生物：2025年前三季度净利润约6053万元

Company Performance - Meikang Bio reported a revenue of approximately 1.136 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 19.27% [1] - The net profit attributable to shareholders was approximately 60.53 million yuan, down 73.02% year-on-year [1] - Basic earnings per share were 0.1576 yuan, reflecting a decrease of 73.03% compared to the previous year [1] Market Context - As of the report, Meikang Bio's market capitalization stood at 4 billion yuan [2] - The A-share market has recently surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology leading the market's transformation [2]